These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28849119)

  • 1. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
    Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
    Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.
    Liu Y; Lv G; Bai J; Song L; Ding E; Liu L; Tian Y; Chen Q; Li K; Liu X; Ding Y
    BMC Cancer; 2022 Apr; 22(1):421. PubMed ID: 35439951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of
    Chen Q; Fu Q; Pu L; Liu X; Liu Y
    J Int Med Res; 2022 Feb; 50(2):3000605221075511. PubMed ID: 35118889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
    Ta L; Xuan C; Xing N; Zhu X
    Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.
    Zhao H; Zhao H; Xia X; Liu X
    Mol Med Rep; 2018 May; 17(5):7451-7459. PubMed ID: 29568870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
    Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
    Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR-103a.
    Ye ZH; Gui DW; Wang XY; Wang J; Fu JL
    J Clin Lab Anal; 2022 Jun; 36(6):e24422. PubMed ID: 35466471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.
    Wei CH; Wei LX; Lai MY; Chen JZ; Mo XJ
    World J Gastroenterol; 2013 Feb; 19(8):1239-46. PubMed ID: 23482887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
    Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
    Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.